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Abstract The serotonin receptor 5-HT1A ligand 4-[
18F]
fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-
2-pyridinyl-benzamide (p-[18F]MPPF) was produced by a
simplified method of Le Bars et al. Traditional oil bath
heating was compared to microwave heating. Various
radioanalytical methods, radio-Thin Layer Chromatogra-
phy (TLC), High Pressure Liquid Chromatography (HPLC)
and Mass Spectrometry (MS), were compared in the
evaluation of the labelled product(s). The crude reaction
mixture consisted of p-[18F]MPPF and 2–4 radioactive
by-products eluting after the product fraction, and the
reverse-phase HPLC method failed occasionally to sepa-
rate p-[18F]MPPF from the radioactive by-product with
close retention time. The heating method had no significant
effect on the composition of labelled by-products. In
LC-(ESI)-MS analysis of p-[18F]MPPF the labelled product
was identified with m/z ratio of 435 ([M ? H?]). The other
HPLC fractions were measured to have following
m/z ratios: (1) 327; 349; (675) (2) 402; 407/408; (791) and
(3) 436, suggesting different kind of decomposition of the
labelled product and/or the inactive precursor. The ion trap
mass spectrometer was sufficient for the qualitative anal-
ysis of p-[18F]MPPF. However, differentiation of by-
products arising from the decomposition of p-[18F]MPPF
or from its precursor p-MPPNO2 proved to be challenging.
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Introduction
Assessment of radiochemical incorporation yield and pos-
sible radiolabelled by-products is important in developing a
synthesis method for any radiolabelled product. Thin Layer
Chromatography (TLC) and High Pressure Liquid Chro-
matography (HPLC) combined with radioactivity detection
are common tools for radiochemical analyses. However,
both these methods have often limitations concerning e.g.
sensitivity, resolution and/or practicality [1] and more than
one radioanalytical method is needed to evaluate reliably
the radiochemical incorporation of the desired radiola-
belled product [2]. Identification of all radiolabelled
products with the above-mentioned methods requires deep
understanding of reaction mechanisms as well as avail-
ability of number of non-radioactive references. All refer-
ences are rarely available and may be problematic to
synthesise. However, Mass Spectrometry (MS) may solve
this problem, being a more sensitive tool for qualitative
analyses of radiopharmaceuticals [3–5].
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Development of radiosynthesis for various 5-HT1A recep-
tor ligands such as 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-
1-piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-[18F]MPPF)
[6, 7], [18F]FBWAY [8] and 18F-mefway [9] have been
reported in the literature. Production of p-[18F]MPPF and the
desmethyl analogue p-[18F]DMPPF [10] are examples of
radiosynthesis where the labelling reaction is a straightfor-
ward nucleophilic substitution of a corresponding nitro-
precursor with fluorine-18. However, separation of p-[18F]
MPPF from its inactive precursor and labelled side-products
is challenging and complex radioHPLC methods are needed
for the analysis/purification of the crude product [6, 7, 11].
We have previously reported the production of p-[18F]
MPPF with moderate radiochemical yield [12]. However,
labelled side-products were not identified. The aim of
this study was to estimate the effect of the labelling
(heating) method on the formation of unwanted side-
products and therefore the radiochemical yield of p-[18F]
MPPF. p-[18F]MPPF was produced by a slightly modi-
fied method of Le Bars et al. [7] and traditional oil bath
heating was compared to microwave (MW) heating.
Three radioanalytical methods were used in order to
identify the labelled impurities: radio-TLC, -HPLC and
-MS. Various chromatographic conditions were tested in
order to optimise the analytical methods.
Experimental
Materials
The inactive precursor 4-nitro-N-[2-[1-(methoxyphenyl)-1-
piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-MPPNO2)
and the fluorinated standard (p-MPPF) were kindly supplied
by Professor Christer Halldin from the Karolinska Institute,
Stockholm, Sweden. The precursor and standard were
synthesised by a 3- and 4-step procedure [13], respectively,
and their quality was verified by 1H-NMR- and TOF MS
ES?-analyses. Other reagents and chemicals were obtained
from commercial sources. HPLC-solvents were of HPLC
grade and other chemicals were of analytical grade.
Production of no-carrier-added [18F]fluoride
No-carrier-added (n.c.a.) [18F]fluoride was produced with
10 MeV protons via the 18O(p,n)18F nuclear reaction using
enriched [18O]H2O. Radioactivity was either added straight
into a solution of Kryptofix2.2.2 (K2.2.2, 22 mg) and
K2CO3 (5.5 mg) in dry acetonitrile, or it was trapped on a
Chromafix cartridge (Macherey–Nagel). [18F]Fluoride was
then eluted with K2CO3-solution (11 mg/mL, 0.6 mL) to a
reaction vial containing a solution of K2.2.2 (22 mg) in dry
CH3CN (1 mL). The reaction mixture was dried by azeo-
tropic distillation at 110 C with CH3CN (2–3 portions of
1 mL) under an argon stream and vacuum. The dry fluo-
rinating agent [K2.2.2/K]?[18F]- was thus obtained.
Radiolabelling of p-[18F]MPPF
The radiosynthesis of p-[18F]MPPF was based on aromatic
nucleophilic substitution of the corresponding nitro-precursor
with fluorine-18 as depicted in Fig. 1. The precursor
p-MPPNO2 (10 mg) in dry DMSO (1.0 mL) was added to the
K[18F]/K2.2.2 complex and the reaction mixture was heated in
a closed vial in an oil bath at 150–180 C for 5–20 min, or in
the microwave oven (Resonance Instrument, Inc., Model
520A). In the MW experiments the heating unit was placed
inside a fume hood and a 5 mL vial (Wheaton or Alltech) with
1 mL solution volume was used. The reaction vial was capped
with a septa (which was pierced by a venting needle) and the
reaction mixture was heated with 40 W for 1 min (3 9 20 s).
Purification of p-[18F]MPPF
The chromatographic system consisted of a Merck-Hitachi
LaChrom L-7100 HPLC pump, a Rheodyne 7010 injector
with a 2 mL injection loop and a LKB Bromma 2151 UV-
detector (k = 270 nm) in series with a NaI(Tl) crystal for
radioactivity detection. The crude reaction mixture was
allowed to cool to room temperature. The crude p-[18F]MPPF
was diluted with HPLC mobile phase (0.8 mL) and injected
on the HPLC column. Semi-preparative HPLC was carried
out on a reverse-phase Waters C18 Symmetry
TM
column
(7 lm, 7.8 9 300 mm) with THF/MeOH/0.05 M NaOAc
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Fig. 1 Synthesis scheme of
p-[18F]MPPF
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(18:27:55; v/v, acetate adjusted to pH 5 with acetic acid) as
eluent at a flow rate of 3 mL/min. The collected product
fraction was evaporated into dryness and the residue was then
dissolved in 1.5 mL of 0.9% NaCl.
(Radio)analytical methods
Labelled products were analysed by radio TLC and -HPLC.
The identity of p-[18F]MPPF was confirmed by comparing
the radiochromatogram with the UV-chromatogram of non-
labelled reference material. In order to identify all the
labelled products, five radioactive fractions were collected
from the semi-preparative HPLC and were analysed also
by LC–MS.
The analytical HPLC apparatus consisted of a PC-con-
trolled system with Waters Millennium32 software, a
Waters 600E pump, a Rheodyne 7125 injector with a 100
lL injection loop, a Waters photodiode array detector
(PDA 996, range 190–400 nm; normally set for 270 nm)
and a NaI(Tl) crystal for radioactivity detection. A Waters
reverse-phase Symmetry
TM
column (C18, 3.5 lm, 4.6 9
150 mm) was used with THF/MeOH/0.05 M NaOAc
(17:28:55; v/v, acetate adjusted to pH 5) as an eluent at a
flow rate of 0.5 mL/min.
TLC was carried out using silica gel plates (60 F254,
Merck) and CH3CN:H2O (90:10%) as mobile phase. UV
visualisation was accomplished with a UV-lamp at
254 nm. Radioactivity was detected with a Raytest Mini-
Gita TLC-scanner and/or by digital Photo Stimulated
Luminescence (PSL) autoradiography using Fuji Imaging
Plates (BAS-TR2025) and a Fuji Analyzer BAS-1800.
The MS studies were done using a Bruker Daltonics
Esquire 3000 instrument with an electron spray ionisation-
Ion trap MSn System (ESI–MS). The inactive precursor p-
MPPNO2 and the product reference p-MPPF were analysed
first by a direct infusion technique. The lowest detection limit
for the LC-(ESI)-MS method was not determined, but even
the concentration of 2 pg/lL (4.6 nM) of p-MPPF reference
was analysed easily. Samples were diluted in methanol and a
solution of CH3CN:H2O 20:80% (1% of HCOOH added for
the ionisation). The concentrations of the samples were
30 lM. The preparative HPLC fractions were analysed by a
LC–MS technique with an Agilent 1100 liquid chromatog-
raphy system and a Waters XBridge reverse phase column
(C18, 3.5 lm, 2.1 9 150 mm). CH3CN:H2O in ratio 80:20%
was used as a mobile phase at a flow rate of 0.2 mL/min. All
HPLC samples were diluted in water with a ratio of 1:9 (v/v).
An autosampler was used for injection with the injection
volume of 5 lL. The radioactivity of the measured fractions
was evaluated with a dose rate meter beside the inlet of ESI.
Stability of the substituted benzamides was studied by
cold synthesis tests in which either the precursor
p-MPPNO2 or the product reference p-MPPF was heated in
similar conditions as in the radiosynthetic procedure and
the crude reaction mixture was injected into semi-pre-
parative HPLC.
Results and discussion
Radiosynthesis of p-[18F]MPPF
The radiochemical incorporation yield of p-[18F]MPPF
using oil bath heating was 27.9 ± 9.5% (mean ± SD,
measured by radioHPLC). This resulted in 3.7 ± 2.4 and
2.5 ± 0.6% overall decay-corrected radiochemical yield
(mean ± SD) for the purified and final, formulated p-[18F]
MPPF, respectively. A considerable amount of radioac-
tivity remained in the reaction vial, the HPLC injector and
on the HPLC column. The radiochemical purity of the
p-[18F]MPPF was C95% (by radio TLC). The highest
incorporation yield of p-[18F]MPPF was reached already
within 5 min reaction time at 170–180 C, prolonging the
reaction time did not improve the yield. A lower reaction
temperature (150 C) with longer heating time (20 min)
was also tested resulting in similar or somewhat lower
incorporation yield of p-[18F]MPPF. MW heating did not
increase the radiochemical yield of p-[18F]MPPF either,
although it has been reported to be beneficial in fluorine-18
labelling of benzamides [7, 14].
The radioHPLC analysis showed that, independent of
the heating method, the crude reaction mixture consisted of
p-[18F]MPPF and 2–4 labelled impurities eluting after the
product fraction. The results are presented in Fig. 2. The
semi-preparative HPLC method [7] failed occasionally to
Fig. 2 Analytical radioHPLC chromatogram of crude p-[18F]MPPF.
Results by labelling of (a) 1st batch and (b) 2nd batch of p-MPPNO2
are presented together in the figure
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separate p-[18F]MPPF from its radioactive by-product with
close retention time. The crude p-[18F]MPPF in DMSO
was diluted with mobile phase and injected straight into
HPLC. Changing the solvent into MeOH/THF by the
reported method [7] was tested but it did not have signif-
icant effect on the purification of p-[18F]MPPF by HPLC
and this purification step was excluded from the synthesis
procedure. The possible effect of DMSO on the stability of
p-[18F]MPPF was proved to be negative by cold synthesis
test with p-MPPF. Specific retardation of the product in the
HPLC column, which would give explanation to the late
eluting radioactive peak, was not detected either. In addi-
tion, the radio TLC analysis of the HPLC-fractions col-
lected from the radiosynthesis resulted in Rf values of 0.31
and 0.64 for p-[18F]MPPF (fraction 1) and for the late
eluting peak (fraction 5), respectively. The labelled impu-
rities eluting between them showed no retention and were
detected with the solvent front. RadioHPLC analyses of the
separated radioactive fractions were comparable to the
analysis of crude p-[18F]MPPF. As expected the purified
product eluted at about 13.5 min, one major by-product
(fraction 2) had a 2–3 min longer retention time, and the
most lipophilic by-product (fraction 5) had a retention time
as long as 45 min. Unexpectedly, this by-product became a
major radioactive product when a oily and a less soluble
batch of p-MPPNO2 was used as a precursor.
Degradation of the inactive precursor p-MPPNO2 and
labelling of the fragments was considered as the reason for
low radiochemical yield of p-[18F]MPPF and for the for-
mation of a high number of side-products. It has been
reported that sulphonamides are susceptible for amide
hydrolysis, e.g. WAY-100634 is formed from p-MPPNO2
[15]. In the radiosynthesis of the trifluoromethyl derivative
of p-[18F]MPPF, acidic water was added into crude product
to prevent precipitation of the nitro precursor and the
reaction mixture was cooled to prevent degradation of the
product in the acidic environment [14]. Defraiteur et al.
[10] reported thermal sensitivity of the p-MPPNO2 deriv-
ative, MEM-MPPNO2 in the radiosynthesis of p-D[
18F]
MPPF. In our stability test on the precursor, comparison of
radioHPLC analyses before and after the heating showed
decrease in the relative amount of p-MPPNO2. Degrada-
tion products with similar or higher lipophilicity than
p-MPPNO2 were not detected. However, the relative amount
of peak with short (4.5 min) retention time increased.
Based on the radio TLC and HPLC analyses it was diffi-
cult to draw conclusions of the formation of various labelled
products during the radiosynthesis of p-[18F]MPPF. There-
fore characterization by MS was used. LC–MS data of the
analysed fractions is shown in Fig. 3. The radiochemical
yield of p-[18F]MPPF in the test syntheses was low but it was
shown that the mass of the isolated product fraction
(RT = 14 min) corresponded the molecular mass of the
p-[18F]MPPF, i.e. m/z 435 ([M ? H?]). The inactive product
eluting from semi-preparative HPLC at 20 min was identi-
fied as the non-labelled precursor p-MPPNO2 with m/z 462
([M ? H?]). However, analysis of the samples from labelled
HPLC-fractions resulted in various peaks, e.g. as high as
m/z of 509 was measured as an impurity together with
p-[18F]MPPF, suggesting that the non-labelled impurities
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(and adduct ions formed from them) were interfering with
the measurements. In order to get more information on the
possible origin of the various mass peaks the inactive pre-
cursor p-MPPNO2 was analysed separately and the results
are shown in Fig. 4. Using a direct infusion technique m/z of
462 ([M ? H?]) was measured, as expected. However, the
spectra showed also peaks at m/z 270 and 327. The origin of
the latter peak was not identified but the loss of m/z 192
suggests reaction of basic nitrogen on the piperazinyl moiety
of p-MPPNO2. The molecular peak corresponding 461 u was
isolated and fractionated in MS2-mode and a similar major
fractionated peak was found at m/z of 270. In MS3 it has also a
fractionated peak with 120 smaller m/z ratio, which is likely a
result from cleavage of the amide bond. Similar fractionation
was detected for the inactive product reference p-MPPF i.e.
peaks with m/z 435 and 243 (and 123 in MS2) were measured.
However, in the LC–MS analysis of p-[18F]MPPF mainly m/
z ratios higher than 400 were measured for the radioactive
by-products and therefore these by-products cannot arise
from C–N cleavage and/or amide hydrolysis of the final
product. Cleavage of methoxy group from the phenyl ring of
p-[18F]MPPF by hydrolysis is also unlikely to happen as it
was shown in the experiments of Defraiteur et al. However,
sensitivity to radiolysis was reported for the desmethyl
analogue p-D[18F]MPPF [10]. In our study all analyses were
done without concentration, therefore radiolysis was not
considered to influence the result. The possible degradation
sites that were considered for the substituted benzamides are
marked in Fig. 5.
Evaluation of chromatographic methods
Optimisation of the chromatographic methods for the ra-
diosynthesis of p-[18F]MPPF proved to be challenging.
With radioHPLC the labelled product had to be separated
from its inactive precursor as well as from various labelled
by-products. Separation with the current semi-preparative
method [7] was occasionally unsatisfactory and some
variation was observed in retention times. Therefore vari-
ous eluent conditions were tested, as presented in Table 1.
With CH3CN:0.01 M H3PO4 (in ratio of 10:90) p-MPPNO2
eluted from the reverse-phase column before p-MPPF until
the pH (adjusted with different ratios of NaH2PO4:Na2
HPO4) was raised (from 2.7) to 5.3. Although neutralizing
p-MPPF and p-MPPNO2 by increasing the pH of the
phosphate buffer seemed to improve their separation, with
pH close to pKa values even a small pH change affected
the retention and caused variation in retention times.
The pKa values of p-MPPNO2 and p-MPPF (6.67 and 6.68,
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Fig. 4 Mass spectra of p-MPPNO2 and p-MPPF measured by direct
infusion ESI–MS technique
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Fig. 5 Molecular structure of p-[18F]MPPF (R = 18F) and p-MPP
NO2 (R = NO2). Drawn lines delineate considered degradation sites.
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Table 1 The average retention times (RT) of p-MPPF and p-MPPNO2 in reverse-phase column using different HPLC conditions
Eluent Ratio pH Flow
(mL/min)a
RT (MPPF)
(min)a
RT (MPPNO2)
(min)a
Flow
(mL/min)b
RT (MPPF)
(mL/min)b
RT (MPPNO2)
(min)b
THF:MeOH:0.05 M NaOAc 18:27:55 5 0.5 12.5 18 2 15 22
THF:CH3CN:0.01 M NaOAc 6:29:65 5 1 10.5 13.5 5 18 24
5:34:61 5 1 6.5 8.5
5:35:59 5 1 7.5 8.5 5 10 13
CH3CN:0.01 M H3PO4 10:90 6.7 1 4.0 5.0 4 5.5 7.0
THF:MeOH:0.05 M NH4Ac 19:31:50 6.7 2 20 25
a Analytical, b semi-preparative C18 symmetry
TM column
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respectively) [16] are also very close to each other.
A HPLC method/column, based on e.g. polar interactions,
might therefore be appropriate for the purification of
p-[18F]MPPF.
Conclusions
The p-[18F]MPPF was produced with moderate-low
radiochemical yield and heating with MW did neither
prevent the formation of radioactive by-products nor
increase the yield as compared to conventional heating.
Conventional radioanalytical methods (radio TLC and
HPLC) without a broad reference material were inadequate
in the assessment of the various labelled products, and
characterisation by a more complex method, MS, was
needed. The sensitivity of the ion trap MS is sufficient for
the qualitative analysis of p-[18F]MPPF. Degradation on
the piperazinyl moiety of reference compounds p-MPPF
and p-MPPNO2 was shown in the (ESI)-MS analysis.
However, LC–MS studies on p-[18F]MPPF suggested
decomposition of the labelled product and/or precursor
through an other route.
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